Collecting data on a patient’s intraocular pressure(IOP) is instrumental in diagnosing and treating glaucoma. However, continuous monitoring of IOP is difficult with traditional tools. Now, German company, Implandata, has developed an eye implant that can measure spikes in pressure over time, and wirelessly transmit the data to a patient’s physician. The device was previously tested in New Zealand white rabbits, but in 2011 the first human patient received the implant as part of a clinical trial. The results have been successful, as the implant was not rejected by the host’s body and lasts, on average, three years. Implandata is preparing to expand their trials and include more patients, potentially revolutionizing the way in which glaucoma is diagnosed and treated.
For more information, watch the video above (warning, graphic content).